Analyst Ratings for Tyra Biosciences (TYRA)
TYRA Rating Summary
TYRA Price Target Summary
- Highest: $59.00 (Barclays)
- Lowest: $42.00 (Piper Sandler)
- Average: $50.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$50.67 (+44.6%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$50.67 (+44.6%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/24/2026 | Cantor Fitzgerald | Li Wa | New Coverage | Overweight (N/A) |
N/A (N/A) |
33.30 (35.04) |
5.23% | Details |
| 2/10/2026 | William Blair | Sami Corwin | New Coverage | Outperform (N/A) |
N/A (N/A) |
30.50 (35.04) |
14.89% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
